Genotyping common FSHR polymorphisms based on competitive amplification of differentially melting amplicons (CADMA).

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 11, 2014, Pages 1427-1436

  Borgbo, Tanni ^a,b   Sommer Kristensen, Lasse ^b   Lindgren, Ida ^c   Yding Andersen, Claus ^b   Hansen, Lise Lotte ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b University of Copenhagen   (Denmark)

^c LUND UNIVERSITY   (Sweden)

Author keywords

CADMA; Fertility treatment; FSHR polymorphisms; Genotype analysis; Pharmacogenetics

Indexed keywords

FOLLITROPIN RELEASING FACTOR; GENOMIC DNA; FOLLITROPIN RECEPTOR;

ANALYTIC METHOD; ARTICLE; COMPETITIVE AMPLIFICATION OF DIFFERENTIALLY MELTING AMPLICONS; DNA EXTRACTION; DNA POLYMORPHISM; GENOTYPE; INFERTILITY THERAPY; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; DNA SEQUENCE; EVALUATION STUDY; GENETIC POLYMORPHISM; GENETICS; GENOTYPING TECHNIQUE; NUCLEIC ACID AMPLIFICATION;

GENOTYPING TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMORPHISM, GENETIC; RECEPTORS, FSH; SEQUENCE ANALYSIS, DNA;

EID: 84912030790     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-014-0329-6     Document Type: Article

References (26)

1. Alviggi C et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol. 2013;11:51.
2. Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol. 2012;10:9.
3. Behre HM et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005;15:451–6.
4. La Marca A et al. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil Steril. 2013;99:970–8.
5. Laan M, Grigorova M, Huhtaniemi IT. Pharmacogenetics of follicle-stimulating hormone action. Curr Opin Endocrinol Diabetes Obes. 2012;19:220–7.
6. Simoni M, Casarini L. Potential for pharmacogenetic use of FSH: a 2014-and-beyond view. Endocrinol: Eur. J; 2013.
7. Desai SS et al. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod Biomed Online. 2013;27:400–6.
8. Klinkert ER et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online. 2006;13:687–95.
9. Lazaros L et al. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI. J Reprod Med. 2013;58:395–401.
10. Lledo B et al. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics. 2013;23:262–8.
11. Perez MM et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365–9.
12. Yan Y. Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study. PLoSOne. 2013;8:e78138.
13. Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab. 2011;103:388–93.
14. Boudjenah R. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoSOne. 2012;7:e38700.
15. Kristensen LS, Andersen GB, Hager H, Hansen LL. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis. Hum Mutat. 2012;33:264–71.
16. Kristensen LS, Kjeldsen TE, Hager H, Hansen LL. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer. BMC Cancer. 2012;12:548.
17. Lindgren I, Giwercman A, Axelsson J, Lundberg GY. Association between follicle-stimulating hormone receptor polymorphisms and reproductive parameters in young men from the general population. Pharmacogenet Genomics. 2012;22:667–72.
18. Gromoll J, Simoni M. Genetic complexity of FSH receptor function. Trends Endocrinol Metab. 2005;16:368–73.
19. La MA et al. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod. 2013;28:1369–74.
20. Kwok S, Chang SY, Sninsky JJ, Wang A. A guide to the design and use of mismatched and degenerate primers. PCR Methods Appl. 1994;3:S39–47.
21. Morlan J, Baker J, Sinicropi D. Mutation detection by real-time PCR: a simple, robust and highly selective method. PLoSOne. 2009;4:e4584.
22. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem. 2003;49:853–60.
23. Gundry CN et al. Base-pair neutral homozygotes can be discriminated by calibrated high-resolution melting of small amplicons. Nucleic Acids Res. 2008;36:3401–8.
24. Kristensen LS, Dobrovic A. Direct genotyping of single nucleotide polymorphisms in methyl metabolism genes using probe-free high-resolution melting analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:1240–7.
25. De La Vega FM, Lazaruk KD, Rhodes MD, Wenz MH. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System. Mutat Res. 2005;573:111–35.
26. Casarini L, Pignatti E, Simoni M. Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Rev Endocr Metab Disord. 2011;12:303–21.